Wolfgang Miesbach: Therapeutic Potential of Protein S Inhibition in Glanzmann Thrombasthenia
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn about a recent article by Rim Diab et al, published in ASH, adding:
“Honored to have attended last weekend’s EHA‑SWG Scientific Meeting on Bleeding and Platelet Disorders, where Rim Diab from the Anne Angelillo-Scherrer group presented her inspiring work on ‘Enhancing Hemostasis in Glanzmann Thrombasthenia via Protein S Inhibition.’
I particularly appreciated how she concluded by reminding us that Glanzmann himself was a Swiss pediatrician who first described this rare platelet disorder in 1918 during his tenure at the Children’s Hospital in Bern, Switzerland — beautifully linking the roots of the disease to today’s one of the most exciting haemostasis research.”
Title: Enhancing hemostasis in glanzmann thrombasthenia via protein S inhibition
Authors: Rim Diab, Tanja Knopp, Mathieu Fiore, Sonia Avoue-celerier, Léonard Julien Simon Schacher, Raja Prince-Eladnani, Anne Angelillo-Scherrer

Other posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Sep 6, 2026, 16:41Christina (Tina) P.: APS – How it Happens in Your Blood, the Warning Signs, and What to Do about It
-
Sep 6, 2026, 16:33Jose Angel Nicolas Avila: How Tissue Mitochondrial Activity Dictates Macrophage Pool Size
-
Sep 6, 2026, 16:23Kevin Buda: Many High-Risk PE Patients Have Contraindications to Thrombolysis
-
Sep 6, 2026, 16:16Venk Murthy: 2018 vs 2026 ACC/AHA Lipid Guidelines – A Shift From RCTs to Expert Opinion?
-
Sep 6, 2026, 16:11Silmara Montalvão: Improving Global Hemophilia Diagnostics Through Sustained External Quality Assessment
-
Sep 6, 2026, 14:50Mohamed F Doheim: Unraveling the Symphony of Stroke Management
-
Sep 6, 2026, 14:47Ahmed Bennis: E-Cigarette Use and Early Cardiovascular Risk in Young Adults
-
Sep 6, 2026, 14:46William Wallace: Iron Deficiency Can be Present Before Hemoglobin Falls and Before Anemia Appears
-
Sep 6, 2026, 14:15Listening to One Another Drives Innovation and Better Therapies in Hemophilia Care – Global Hemophilia Report